QCG
AGN

Quadrant Capital Group’s Allergan plc AGN Stock Holding History

Quadrant Capital Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,861
Closed -$511K – 2515
2020
Q1 		$511K Buy
2,861
+87
+3% +$16.4K 0.09% 199
2019
Q4 		$509K Buy
2,774
+325
+13% +$58.6K 0.06% 299
2019
Q3 		$396K Buy
2,449
+1,389
+131% +$226K 0.06% 336
2019
Q2 		$170K Sell
1,060
-948
-47% -$131K 0.03% 647
2019
Q1 		$284K Buy
2,008
+943
+89% +$137K 0.05% 376
2018
Q4 		$134K Sell
1,065
-130
-11% -$21.3K 0.04% 496
2018
Q3 		$216K Buy
1,195
+181
+18% +$33.3K 0.06% 223
2018
Q2 		$162K Sell
1,014
-6
-0.6% -$963 0.06% 285
2018
Q1 		$164K Buy
1,020
+46
+5% +$7.72K 0.06% 288
2017
Q4 		$149K Sell
974
-83
-8% -$14.9K 0.06% 291
2017
Q3 		$203K Sell
1,057
-144
-12% -$33.5K 0.08% 202
2017
Q2 		$235K Buy
1,201
+16
+1% +$3.76K 0.1% 163
2017
Q1 		$274K Buy
1,185
+330
+39% +$76.8K 0.12% 143
2016
Q4 		$175K Sell
855
-405
-32% -$83.9K 0.09% 168
2016
Q3 		$280K Buy
1,260
+385
+44% +$94.1K 0.18% 98
2016
Q2 		$195K Sell
875
-220
-20% -$50.7K 0.13% 128
2016
Q1 		$286K Sell
1,095
-156
-12% -$44.7K 0.19% 89
2015
Q4 		$384K Sell
1,251
-128
-9% -$38.1K 0.27% 78
2015
Q3 		$372K Sell
1,379
-86
-6% -$26.4K 0.26% 72
2015
Q2 		$440K Buy
+1,465
New +$437K 0.28% 66

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Quadrant Capital Group's AGN Position: Q2 2020 in Review

Quadrant Capital Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,861 shares — an estimated $511K sold.

Quadrant Capital Group first reported a position in AGN in Q2 2015 and held it in 20 quarters. The position peaked at $511K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Quadrant Capital Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Quadrant Capital Group sold 2,861 Allergan plc shares in Q2 2020, an estimated $511K.
  • Quadrant Capital Group first reported a position in Allergan plc in Q2 2015 and held it in 20 quarters.
  • Quadrant Capital Group's Allergan plc position peaked at $511K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Quadrant Capital Group's 13F filing for Q2 2020, filed 13 Aug 2020.